ArticleCureus2025
Patient Plan Customization in Hypofractionated CyberKnife Radiosurgery for Extensive Brain Metastases Within a Resource-Constrained Low-Middle-Income Country.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain metastasis (BM) carries a dismal prognosis. In the setting of advanced breast cancer, BM has a formidable outcome, yet radiosurgery has played a pivotal role in palliating patients. Here, we present the case of a 62-year-old hypertensive female with biopsy-proven, triple-negative, invasive ductal carcinoma of the left breast (stage IV disease). Whole-brain radiotherapy (WBRT) failed to achieve radiological and clinical response for 60 intracranial metastatic space-occupying lesions. Her presenting complaint of intractable headache was accompanied by a normal neurological examination. A customized plan for stereotactic radiosurgery via CyberKnife S7 was utilized with a 2,200 cGy dose and 68% isocurve over five fractions on alternate days. Redo WBRT was not performed owing to the patient's comorbidities, age, and risk of cognitive deficits. Radiological remission of 81% and 88% with no neurological deficits was achieved at the fourth and eighth months of follow-up. To our knowledge, this is the first case of 60 secondaries in the human brain from a breast primary successfully managed with CyberKnife stereotactic radiosurgery, achieving remarkable radiological regression while preserving clinical function. A customized plan considering the patient's factors and risk versus benefit assessment is advisable in all cases of metastatic brain disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.